REBECCA (BECCA) JONES McKNIGHT is an FDA regulatory and compliance partner at DLA Piper LLP (US). Becca advises clients who develop, make and distribute FDA-regulated products and who play a
part in the investigation and delivery of healthcare products and services. She provides strategic regulatory counseling to help clients commercialize products and services and establish and maintain compliant operations. She has extensive experience in developing policies and procedures for FDA and healthcare compliance; conducting proactive reviews, risk assessments and internal compliance investigations; and correcting and remediating non-compliance. Her FDA experience spans a range of products, with an emphasis on medical device, pharmaceutical and biological drug regulation and compliance. Her work has also focused on potential compliance matters, under the Anti-Kickback Statute, Sunshine Act and other laws, raised by relationships between physicians and industry, including those arising in the context of clinical research; product development; and product sales, purchasing and promotion. She provides advice on the intersection of clinical trial and healthcare law with “big data” business models, addressing regulatory and compliance considerations for the collection, sharing and use of patient and product information. Becca earned her JD at the University of Texas School of Law in 2003, with honors, and her BA in Politics from Wake Forest University in 2000, Phi Beta Kappa. In 2017 and 2018, Becca was named a Super Lawyers Rising Star in the area of Food and Drug law, in a joint project of Super Lawyers and Texas Monthly magazine. In 2021 Becca was named to The American Lawyer’s inaugural list of South Trailblazers. The list recognizes professionals in the South “who have moved the needle in the legal industry.”